Quote | SelectQuote Inc. (NYSE:SLQT)
Last: | $2.88 |
---|---|
Change Percent: | 0.0% |
Open: | $3.05 |
Close: | $2.88 |
High: | $3.075 |
Low: | $2.86 |
Volume: | 947,839 |
Last Trade Date Time: | 05/17/2024 03:00:00 am |
News | SelectQuote Inc. (NYSE:SLQT)
2024-05-09 17:00:11 ET Image source: The Motley Fool. SelectQuote (NYSE: SLQT) Q3 2024 Earnings Call May 09, 2024 , 9:00 a.m. ET Operator Continue reading For further details see: SelectQuote (SLQT) Q3 2024 Earnings Call Transcript
2024-05-09 16:18:02 ET SelectQuote, Inc. (SLQT) Q3 2024 Results Conference Call May 09, 2024 09:00 AM ET Company Participants Matt Gunter - Investor Relations Tim Danker - Chief Executive Officer Ryan Clement - Chief Financial Officer Bob Grant - President ...
Message Board Posts | SelectQuote Inc. (NYSE:SLQT)
Subject | By | Source | When |
---|---|---|---|
$SLQT bears are running | JohnCM | investorshub | 05/05/2023 2:05:30 PM |
short squeeze all day | Invest-in-America | investorshub | 05/03/2023 5:02:41 PM |
Price gaining | Golden Cross | investorshub | 05/01/2023 10:03:33 PM |
$SLQT The gaining | JohnCM | investorshub | 05/01/2023 2:13:41 AM |
news out | Mt. Blanc | investorshub | 04/29/2023 6:52:27 AM |
News, Short Squeeze, Breakout and More Instantly...
SelectQuote Inc. Company Name:
SLQT Stock Symbol:
NYSE Market:
2024-05-09 17:00:11 ET Image source: The Motley Fool. SelectQuote (NYSE: SLQT) Q3 2024 Earnings Call May 09, 2024 , 9:00 a.m. ET Operator Continue reading For further details see: SelectQuote (SLQT) Q3 2024 Earnings Call Transcript
Third Quarter of Fiscal Year 2024 – Consolidated Earnings Highlights Revenue of $376.4 million Net income of $8.6 million Adjusted EBITDA* of $46.6 million Raising Fiscal Year 2024 Guidance Ranges: Revenue expected in a range of $1.25 billion to $1.3 billion vs ...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...